Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Revised Communication Strategy

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Feb 17, 2024 10:39pm

219 Views

Post# 35886334

RE:RE:RE:RE:RE:RE:RE:RE:RE:Revised Communication Strategy

A pretty good summary BJ

There is at least one more option / possibility. Less likely perhaps but NOT impossible IMO.

Baxter decides that the Trial has been sufficiently derisked after a slightly more in-depth look-see (and a re-read of JK's paper). And then decides it's go time for their IPO and that they need to muster up some high margin sizzle toute de suite for their imminent IPO.... rather than put it off til fall or winter. Biden, Yellen and Powell can only create the appearance of a strong economy for so long, pre-election. And who wants to IPO during a down market ?

Perhaps the least likely option, but a possibility nonetheless.

MM

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale